Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dong-E-E-Jiao is a prominent Chinese pharmaceutical company and a subsidiary of China Resources Pharmaceutical Group, specializing in Traditional Chinese Medicine (TCM). The company is the world's largest producer of Ejiao (donkey-hide gelatin), a highly valued substance in Chinese medicine used for blood enrichment and immune support. Its product portfolio includes the flagship Ejiao blocks, Compound Ejiao Jiang oral liquid, and various health supplements and beauty products. Dong-E-E-Jiao maintains a vertically integrated supply chain, including donkey breeding bases and advanced GMP-certified manufacturing facilities. The company is listed on the Shenzhen Stock Exchange and is recognized as a national intangible cultural heritage site for its traditional production techniques.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Resources Dong'e Ejiao.